Ligand validation:3NVN

NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose

NDG is a Ligand Of Interest in 3NVN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NVN_NDG_B_2	3%	63%	0.37	0.705	0.62	0.76	-	-	0	0	93%	0.9333
3NVN_NDG_A_1	2%	57%	0.357	0.639	0.68	0.96	-	1	0	0	93%	0.9333
3NVN_NDG_B_7	0%	65%	0.61	0.221	0.76	0.56	-	-	1	0	93%	0.9333
3NVQ_NDG_A_4	28%	53%	0.221	0.889	0.71	1.1	-	2	0	0	93%	0.9333
4GVF_NDG_A_401	97%	32%	0.06	0.978	1.66	1.18	4	2	0	0	100%	0.7
2UVO_NDG_B_1176	97%	71%	0.059	0.975	0.42	0.68	-	-	0	0	100%	1
2ZUV_NDG_A_2001	97%	50%	0.066	0.978	0.54	1.38	-	2	0	0	100%	1
5A3L_NDG_C_1237	96%	58%	0.066	0.974	0.44	1.15	-	2	0	0	100%	0.5
8R3D_NDG_E_101	95%	54%	0.057	0.963	0.78	0.98	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.